
Andy Abril
@andyabrilmd
Rheumatologist at @MayoClinic. #Bilingual (English and Spanish). Tweets are mine, not Mayo’s mayoclinic.org/biographies/ab…
ID: 837681473993990144
03-03-2017 15:10:01
90 Tweet
406 Followers
69 Following




Exciting to hear about 5 trials for #GCA 1. ABAGART (#Abatacept) 2. METOGIA (#tocilizumab vs MTX) 3. SELECT (#upadacitinib) 4. MAVRILIMUMAB (#gmcsf i) 5. TiTIAN (#secukinumab) Vasculitis Foundation #vasculitis #vcrc











Reading Becker's Hospital Review 22 US hospitals among Newsweek's 100 best in the world beckershospitalreview.com/rankings-and-r…


2020 ACR/VF guidelines for Management of #vasculitis (GCA/TAK, PAN, AAV) published in ACR_Journals! Tons of collaboration and effort with a fantastic team Philip Seo Peter Grayson Peter Merkel Kevin Byram, MD Vasculitis Foundation onlinelibrary.wiley.com/doi/10.1002/ar…


Construyendo relaciones con los colegas de Mayo Clinic Andy Abril en el marco de estrategias de colaboración académica y de futuros proyectos en #investigacion Asociación Colombiana de Medicina Interna Fundación Santa Fe de Bogotá


Vivek Nagaraja Dr. Vivek Nagaraja from Mayo Clinic Arizona delivers masterful review on #Scleroderma Great to see evolution of therapies for this disease Mayo Clinic Rheumatology Review for Primary Care #Orlando Andy Abril


🙌 Proud of this tri-site participation from Mayo Clinic in ✨CONQUEST✨ 1st ever Global ‘Platform Clinical Trial’ in #Rheumatology funded by Scleroderma Research Foundation @SRFCure, that promises to accelerate drug development in #SclerodermaILD ! 👉 conquestssc-trial.org/conquest-study
